This paper is in the following e-collection/theme issue:

Scoping Review Protocols (258) RCTs - Protocols/Proposals (eHealth) (682) Diabetes (267) Diabetes Technology Around the World (33) mHealth for Treatment Adherence (476)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77587, first published .
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol

Authors of this article:

Tooba Laeeq1 Author Orcid Image ;   Ayesha Mehak Kamal2 Author Orcid Image ;   Arbab Burhan Uddin Kasi3 Author Orcid Image ;   Umm E Salma Shabbar Banatwala2 Author Orcid Image ;   Aniqa Baloch2 Author Orcid Image ;   Roberto Sagaribay4 Author Orcid Image ;   Vidhani Goel4, 5 Author Orcid Image ;   Aditi Singh1 Author Orcid Image ;   Kavita Batra4, 6 Author Orcid Image
Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .